Integrating network pharmacology approach and experimental validation to reveal the alleviation of Shenkangning capsule on chronic nephritis
- 1 December 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 299, 115676
- https://doi.org/10.1016/j.jep.2022.115676
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2018YFC1707300, 2018YFC1707302)
This publication has 34 references indexed in Scilit:
- Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates ProteinuriaJournal of the American Society of Nephrology, 2016
- The Changing Landscape of Renal InflammationTrends in Molecular Medicine, 2016
- Recent Advances in Traditional Chinese Medicine for Kidney DiseaseAmerican Journal of Kidney Diseases, 2015
- The involvement of p62–Keap1–Nrf2 antioxidative signaling pathway and JNK in the protection of natural flavonoid quercetin against hepatotoxicityFree Radical Biology & Medicine, 2015
- The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an updateInflammation Research, 2015
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseKidney International, 2013
- Kidney Proximal Tubular Epithelial-Specific Overexpression of Netrin-1 Suppresses Inflammation and Albuminuria through Suppression of COX-2-Mediated PGE2 Production in Streptozotocin-Induced Diabetic MiceThe American Journal of Pathology, 2012
- Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failureAmerican Journal of Physiology-Renal Physiology, 2010
- GlomerulonephritisThe Lancet, 2005
- Cell Biology of the Glomerular PodocytePhysiological Reviews, 2003